Evolving role of cardiac magnetic resonance in cardiac amyloidosis

Figure 1 Clinical readiness of cardiac magnetic resonance techniques in cardiac amyloidosis. Readiness tiers represent the author’s synthesis of the evidence reviewed in this article. They do not correspond to formal recommendation classes or levels of evidence issued by societies. Green: Established clinical use, supported by concordant cohort data and meta-analyses and incorporated into society imaging guidance[1,9,21,34,35]. Amber: Emerging, supported by limited or single-centre evidence and carrying no formal guideline recommendation[3,13,17,24,25,27]. Red: Research use only, confined to small feasibility cohorts[2,11,14].